Please use this identifier to cite or link to this item:
Title: Systemic inflammatory response in a liver transplant recipient: a potential side effect of mycophenolate mofetil.
Austin Authors: Smith, Rebecca ;Testro, Adam G 
Affiliation: Victorian Liver Transplant Unit
Medicine (University of Melbourne)
Issue Date: 28-Mar-2018
Date: 2018
Publication information: BMJ Case Reports 2018; 2018: bcr-2017-223767
Abstract: Mycophenolate mofetil is a commonly used immunosuppressive medication in the postliver transplant setting where gastrointestinal side effects tend to predominate. However, in more recent times, emerging and rare side effects are being reported in the literature. We present a case of a patient who had a significant inflammatory response and associated marked weight loss with the uptitration in dose of mycophenolate mofetil. Extensive investigations were performed to exclude other infective, inflammatory or malignant aetiologies for these symptoms, however no other cause was identified. The patient had the medication ceased and subsequently had a dramatic improvement in his inflammatory markers and regained the weight lost while on the medication.
DOI: 10.1136/bcr-2017-223767
Journal: BMJ Case Reports
PubMed URL: 29592993
Type: Journal Article
Subjects: gastrointestinal system
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Apr 15, 2024

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.